Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 2—February 2004
THEME ISSUE
2004 SARS Edition

SARS Epidemiology

SARS Surveillance during Emergency Public Health Response, United States, March–July 2003

Stephanie J. Schrag*Comments to Author , John T. Brooks*, Chris Van Beneden*, Umesh D. Parashar*, Patricia M. Griffin*, Larry J. Anderson*, William J. Bellini*, Robert F. Benson*, Dean D. Erdman*, Alexander Klimov*, Thomas G. Ksiazek*, Teresa C.T. Peret*, Deborah F. Talkington*, W. Lanier Thacker*, Maria L. Tondella*, Jacquelyn S. Sampson*, Allen W. Hightower*, Dale F. Nordenberg*, Brian D. Plikaytis*, Ali S. Khan*, Nancy E. Rosenstein*, Tracee A. Treadwell*, Cynthia G. Whitney*, Anthony E. Fiore*, Tonji M. Durant*, Joseph F. Perz*, Annemarie Wasley*, Daniel Feikin*, Joy L. Herndon*, William A. Bower*, Barbara W. Kilbourn*, Deborah A. Levy*, Victor G. Coronado*, Joanna Buffington*, Clare A. Dykewicz*, Rima F. Khabbaz*, and Mary E. Chamberland*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 5

Results of diagnostic testing for other infectious respiratory pathogens, U.S. SARS surveillance, March–July, 2003a,b,c

SARS-CoV status Mycoplasma pneumoniae Streptococcus pneumoniae Chlamydia pneumoniaed Legionella pneumophila HMPV Influenza A or B Parainfluenza 1, 2, or 3 RSV Adenovirus Picornaviruse
Positive
Chest imaging resultsf positive 0/2
(0%) 0/1
(0%) 0/2
(0%) 0/2
(0%) 0/1
(0%) 1/1
(100%) 0/1
(0%) 0/1
(0%) 0/1
(0%) --
Negative
Chest imaging results positive 3/24
(13%) 0/16
(0%) 0/24
(0%) 0/24
(0%) 2/22
(9%) 0/21
(0%) 1/22
(5%) 0/22
(0%) 0/22
(0%) 3/10
(30%)
Chest imaging results negative 11/99
(11%) 5/71
(7%) 2/95
(2%) 0/96
(0%) 8/90
(9%) 16/84
(19%) 5/90
(6%) 2/90
(2%) 5/90
(6%) 12/45
(27%)
Undetermined
Chest imaging results positive 3/14
(21%) 1/1
(100%) 0/15
(0%) 0/14
(0%) 1/13
(8%) 1/13
(8%) 2/13
(15%) 0/13
(0%) 1/13
(8%) 4/13
(31%)
Chest imaging results negative 5/61
(8%) 0/1
(0%) 0/61
(0%) 0/60
(0%) 1/47
(2%) 7/47
(15%) 4/47
(9%) 1/47
(2%) 3/47
(6%) 10/46
(22%)











Totals 22/200
(11%) 6/90
(7%) 2/197
(1%) 0/196
(0%) 12/172
(7%) 25/166 (15%) 12/172
(7%) 3/172
(2%) 9/172
(5%) 29/114
(25%)

aSARS, severe acute respiratory syndrome; CoV, coronavirus; HMPV, human metapneumovirus; RSV, respiratory syncytial virus; PCR, polymerase chain reaction.

bDenominators for results of tests vary as specimens of appropriate type and of adequate amount necessary for PCR and serologic testing were obtained only for a subset of case-patients. Positive results shown are those persons for whom evidence of acute infection was demonstrated by serologic and/or PCR testing on the specimens available for testing.

cOnly one of the two SARS-CoV–positive case-patients had evidence of infection with another agent (influenza B). For 22 suspect and probable cases, more than one agent was identified. Combinations included: HMPV, Influenza B (FluB) + S. pneumoniae (N = 1); Mycoplasma, picornavirus + S. pneumoniae (N = 1); Mycoplasma + FluA (N = 5); HMPV + parainfluenza virus (HPIV) (N = 1); C. pneumoniae, adenovirus + FluB (N = 1); Mycoplasma + picornavirus (N = 3); adenovirus + picornavirus (N = 1); Mycoplasma + HPIV (N = 1); HPIV + picornavirus (N = 1); FluB + picornavirus (N = 1); adenovirus + HMPV (N = 1); HPIV + picornavirus (N = 1); HMPV + picornavirus (N = 1); Mycoplasma + picornavirus (N = 1); S. pneumoniae + picornavirus (N = 1); S. pneumoniae + HMPV (N = 1).

dAll specimens tested for serologic or PCR evidence of C. pneumoniae were also tested for evidence of C. psittaci; no acute C. psittaci infections were diagnosed.

eInclusive of rhinovirus and enterovirus.

fPlain film x-ray, computed tomographic scan, etc.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO